High-resolution NMR characterization of low abundance oligomers of amyloid-β without purification

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Kotler, Samuel A ^a   Brender, Jeffrey R ^a   Vivekanandan, Subramanian ^a   Suzuki, Yuta ^a   Yamamoto, Kazutoshi ^a   Monette, Martine ^c   Krishnamoorthy, Janarthanan ^a   Walsh, Patrick ^a   Cauble, Meagan ^a   Holl, Mark M Banaszak ^a,b   Marsh, E Neil G ^a   Ramamoorthy, Ayyalusamy ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c Bruker Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; MACROMOLECULE; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; CHEMISTRY; HUMAN; MACROMOLECULE; METABOLISM; NUCLEAR MAGNETIC RESONANCE; PATHOLOGY; PROTEIN CONFORMATION; PROTEINOSIS;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID; AMYLOID BETA-PEPTIDES; HUMANS; MACROMOLECULAR SUBSTANCES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDE FRAGMENTS; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN CONFORMATION;

EID: 84953931446     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11811     Document Type: Article

References (54)

1. Alzheimer's disease facts and figures. Alzheimer's Dement. 11, 332-384 (2015).
2. Sakono, M. & Zako, T. Amyloid oligomers: formation and toxicity of Abeta oligomers. FEBS J. 277, 1348-58 (2010).
3. Benilova, I., Karran, E. & De Strooper, B. The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes. Nat. Neurosci. 15, 349-57 (2012).
4. Selkoe, D. J. The molecular pathology of Alzheimer's disease. Neuron 6, 487-498 (1991).
5. Lin, H., Bhatia, R. & Lal, R. Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J 15, 2433-2444 (2001).
6. Butterfield, S. M. & Lashuel, H. a. Amyloidogenic protein-membrane interactions: mechanistic insight from model systems. Angew. Chem. Int. Ed. Engl. 49, 5628-54 (2010).
7. Bernstein, S. L. et al. Amyloid β -protein: monomer structure and early aggregation states of Aβ 42 and its Pro19 alloform. J. Am. Chem. Soc. 127, 2075-84 (2005).
8. Ball, K. A., Phillips, A. H., Wemmer, D. E. & Head-Gordon, T. Differences in β -strand populations of monomeric Aβ 40 and Aβ 42. Biophys. J. 104, 2714-24 (2013).
9. Baumketner, A. et al. Amyloid β -protein monomer structure: a computational and experimental study. Protein Sci. 15, 420-8 (2006).
10. Tycko, R. Solid-state N. M. R. studies of amyloid fibril structure. Annu. Rev. Phys. Chem. 62, 279-99 (2011).
11. Schütz, A. K. et al. Atomic-Resolution Three-Dimensional Structure of Amyloid β Fibrils Bearing the Osaka Mutation. Angew. Chem. Int. Ed. Engl. (2014). doi: 10.1002/anie.201408598
12. Petkova, A. T. et al. Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 307, 262-265 (2005).
13. Lu, J.-X. et al. Molecular structure of β -amyloid fibrils in Alzheimer's disease brain tissue. Cell 154, 1257-68 (2013).
14. Vivekanandan, S., Brender, J. R., Lee, S. Y. & Ramamoorthy, A. A partially folded structure of amyloid-beta(1-40) in an aqueous environment. Biochem. Biophys. Res. Commun. 411, 312-6 (2011).
15. Chimon, S. et al. Evidence of fibril-like β -sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β -amyloid. Nat. Struct. Mol. Biol. 14, 1157-64 (2007).
16. Ahmed, M. et al. Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils. Nat. Struct. Mol. Biol. 17, 561-567 (2010).
17. Sarkar, B. et al. Significant structural differences between transient amyloid-β oligomers and less-toxic fibrils in regions known to harbor familial Alzheimer's mutations. Angew. Chem. Int. Ed. Engl. 53, 6888-92 (2014).
18. Scheidt, H. A., Morgado, I. & Huster, D. Solid-state NMR reveals a close structural relationship between amyloid-β protofibrils and oligomers. J. Biol. Chem. 287, 22822-6 (2012).
19. Tay, W. M., Huang, D., Rosenberry, T. L. & Paravastu, A. K. The Alzheimer's amyloid-β (1-42) peptide forms off-pathway oligomers and fibrils that are distinguished structurally by intermolecular organization. J. Mol. Biol. 425, 2494-508 (2013).
20. Lendel, C. et al. A Hexameric Peptide Barrel as Building Block of Amyloid-β Protofibrils. Angew. Chem. Int. Ed. Engl. 53, 12756-60 (2014).
21. Yu, L. et al. Structural characterization of a soluble amyloid beta-peptide oligomer. Biochemistry 48, 1870-7 (2009).
22. Ladiwala, A. R. A. et al. Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity. J. Biol. Chem. 287, 24765-73 (2012).
23. Ono, K., Condron, M. M. & Teplow, D. B. Structure-neurotoxicity relationships of amyloid beta-protein oligomers. Proc. Natl. Acad. Sci. U. S. A. 106, 14745-50 (2009).
24. Luo, J., Wärmländer, S. K. T. S., Gräslund, A. & Abrahams, J. P. Alzheimer peptides aggregate into transient nanoglobules that nucleate fibrils. Biochemistry 53, 6302-8 (2014).
25. Serra-Vidal, B. et al. Hydrogen/Deuterium Exchange-Protected Oligomers Populated during Aβ Fibril Formation Correlate with Neuronal Cell Death. ACS Chem. Biol. 9, 2678-2685 (2014).
26. Stroud, J. C., Liu, C., Teng, P. K. & Eisenberg, D. Toxic fibrillar oligomers of amyloid-β have cross-β structure. Proc. Natl. Acad. Sci. U. S. A. 109, 7717-22 (2012).
27. Jehle, S. et al. Solid-state NMR and SAXS studies provide a structural basis for the activation of alphaB-crystallin oligomers. Nat. Struct. Mol. Biol. 17, 1037-42 (2010).
28. Corsale, C. et al. Entrapment of Aβ (1-40) peptide in unstructured aggregates. J. Phys. Condens. Matter 24, 244103 (2012).
29. Suzuki, Y. et al. Resolution of oligomeric species during the aggregation of Aβ 1-40 using (19)F NMR. Biochemistry 52, 1903-12 (2013).
30. Bertini, I. et al. Formation kinetics and structural features of Beta-amyloid aggregates by sedimented solute NMR. Chembiochem 14, 1891-7 (2013).
31. Bennett, A. E., Griffin, R. G., Ok, J. H. & Vega, S. Chemical shift correlation spectroscopy in rotating solids: Radio frequencydriven dipolar recoupling and longitudinal exchange. J. Chem. Phys. 96, 8624 (1992).
32. Raya, J. et al. Proton Dipolar Recoupling in Resin-Bound Peptides under High-Resolution Magic Angle Spinning. J. Magn. Reson. 157, 43-51 (2002).
33. Pandey, M. K. et al. Proton-detected 2D radio frequency driven recoupling solid-state NMR studies on micelle-associated cytochrome-b(5). J. Magn. Reson. 242, 169-79 (2014).
34. Ramamoorthy, A. & Xu, J. 2D 1H/1H RFDR and NOESY NMR experiments on a membrane-bound antimicrobial peptide under magic angle spinning. J. Phys. Chem. B 117, 6693-700 (2013).
35. Aucoin, D. et al. High-resolution 1H MAS RFDR NMR of biological membranes. J. Magn. Reson. 197, 77-86 (2009).
36. Kotler, S. A. et al. Gangliosides Mediate a Two-Step Mechanism of Membrane Disruption by Beta-Amyloid: Initial Pore Formation Followed by Membrane Fragmentation. Biophys. J. 104, 217A-217A (2013).
37. Bolognesi, B. et al. ANS binding reveals common features of cytotoxic amyloid species. ACS Chem. Biol. 5, 735-40 (2010).
38. Guerrero-Muñoz, M. J., Castillo-Carranza, D. L., Sengupta, U., White, M. A. & Kayed, R. Design of metastable β -sheet oligomers from natively unstructured peptide. ACS Chem. Neurosci. 4, 1520-3 (2013).
39. Narayanan, S. & Reif, B. Characterization of chemical exchange between soluble and aggregated states of beta-amyloid by solution-state NMR upon variation of salt conditions. Biochemistry 44, 1444-52 (2005).
40. Huang, R. et al. NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG. J. Mol. Biol. 416, 108-20 (2012).
41. Hyung, S.-J. et al. Insights into antiamyloidogenic properties of the green tea extract (-)-epigallocatechin-3-gallate toward metalassociated amyloid-β species. Proc. Natl. Acad. Sci. U. S. A. 110, 3743-8 (2013).
42. Fawzi, N. L., Ying, J., Ghirlando, R., Torchia, D. A. & Clore, G. M. Atomic-resolution dynamics on the surface of amyloid-β protofibrils probed by solution NMR. Nature 480, 268-272 (2011).
43. Brender, J. R. et al. Probing the Sources of the Apparent Irreproducibility of Amyloid Formation: Drastic Changes in Kinetics and a Switch in Mechanism Due to Micellelike Oligomer Formation at Critical Concentrations of IAPP. J. Phys. Chem. B 119, 2886-2896 (2015).
44. Walsh, P., Neudecker, P. & Sharpe, S. Structural properties and dynamic behavior of nonfibrillar oligomers formed by PrP(106-126). J. Am. Chem. Soc. 132, 7684-95 (2010).
45. Rhoades, E. & Gafni, A. Micelle formation by a fragment of human islet amyloid polypeptide. Biophys. J. 84, 3480-7 (2003).
46. Carulla, N. et al. Experimental characterization of disordered and ordered aggregates populated during the process of amyloid fibril formation. Proc. Natl. Acad. Sci. U. S. A. 106, 7828-33 (2009).
47. Lopez del Amo, J. M. et al. Structural properties of EGCG-induced, nontoxic Alzheimer's disease Aβ oligomers. J. Mol. Biol. 421, 517-24 (2012).
48. Ladiwala, A. R. A. et al. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers. J. Biol. Chem. 285, 24228-37 (2010).
49. Lee, J., Culyba, E. K., Powers, E. T. & Kelly, J. W. Amyloid-β forms fibrils by nucleated conformational conversion of oligomers. Nat. Chem. Biol. 7, 602-609 (2011).
50. Serio, T. R. Nucleated Conformational Conversion and the Replication of Conformational Information by a Prion Determinant. Science 289, 1317-1321 (2000).
51. Moore, B. D., Rangachari, V., Tay, W. M., Milkovic, N. M. & Rosenberry, T. L. Biophysical analyses of synthetic amyloidbeta( 1-42) aggregates before and after covalent cross-linking. Implications for deducing the structure of endogenous amyloidbeta oligomers. Biochemistry 48, 11796-806 (2009).
52. Hartley, D. M. et al. Transglutaminase induces protofibril-like amyloid beta-protein assemblies that are protease-resistant and inhibit long-term potentiation. J. Biol. Chem. 283, 16790-800 (2008).
53. Townsend, M., Shankar, G. M., Mehta, T., Walsh, D. M. & Selkoe, D. J. Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J. Physiol. 572, 477-92 (2006).
54. Reed, M. N. et al. Cognitive effects of cell-derived and synthetically derived Aβ oligomers. Neurobiol. Aging 32, 1784-94 (2011).